1. Hinsworth H.Diabetes mellitus：a differentiation into insulin-sensitive and insulin-insensitive types.Lancet，1936，1：127-130.

2. Bagdade LD，Bierman EL，Porte D.The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects.J.Clin-Invest，1967，46：1549-1557.

3. Woods SC，Stein LJ，Mckay LD，et al. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature，1979，282（5738）：503-505.

4. Moller DE，Flier GS. Insulin resistance-mechanisms，syndromes，and implications.N Engl J Med，1991，325（13）：938-948.

5. Frayn KN，Coppack SW.Insulin redsiMIlch adipose tissue and coronary heart disease.Clin Sci，1992，82（1）：1-8.

6. Knutson VP，Donnelly PV，Balba Y.et al.Insulin resistance is mediated by a proteolytic fragment of the insulin receptor-J.BiolChem，1995，270（42）：24927-24981.

7. Saltiel AR，Olefsky JM.Thiazolidinediones in the treatment of insulin resistance and type II diabetes.Diabetes，1996，45（12）：1661-1669.

8. Garg A.Insulin resistance in the pathogenesis of dyslipidemia.Diabetes Care，1996，19（4）：387-389.

9.李光伟，潘孝仁，Bennett PH.血浆葡萄糖，胰岛素比值是可靠的胰岛素敏感性指数吗？中华心血管病杂志，1996，2：42-57.

10. Steinberg HO，Chaker H，Learning R，et al.Obesity/insulin resisitance is associated with endothelial dysfunctionimplication for the syndrome of insulin resisitance.J Clin Invest，1996，97（11）：2601-2610.

11. Prort D，Seeley RJ，Woods DG.et al.Obesity，diabetes and the central nervous system. Diabetologia，1998，41：863-881.

12.贾伟平，项坤三，丁炜，等.男性中国人体脂分布与激素模式.中华代谢内分泌杂志，1998，142：78-81.

13.李秀钩，钱荣立.胰岛素抵抗及其临床意义.中国糖尿病杂志，1999，72：163-166.

14. Granberry MC，Fonseca VA.Insulin resistance syndrome：Options for treatment.South Med J，1999，92：2-14.

15. Hermans HMP，Levy JC，Morris RJ.et al.Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes.Diabetologia，1999，42（6）：678-687.

16. Janssen I，Katzmarzyk PT，Ross R，et al.Fitness alters the associations of BMI and waist circumference with total and abdominal fat.Obes Res，2004，12（3）：525-537.

17. Karlsson HK，Zierath JR，Kane S，et al.Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects.Diabetes.2005，54（6）：1692-1697.

18. Kann SE，Hull RL，Utzschneider KM.Mechanisms linking obesity to insulin resistance and type 2 diabetes.Nature，2006，444：840-846.

19. Hamdy O，Porramatikul S，Al-Ozairi E.Etabolic obesity：the paradox between visceral and subcutaneous fat. Curr Diabetes Rev，2006，2（4）：367-373.

20. Park S，Hong SM，Lee JE，et al.Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic beta-cell function and mass through IRS2 in diabetic rats.J Appl Physiol.2007，103 （5）：1764-1771.

21. Fox CS，Massaro JM，Hoffmann U，et al.Abdominal visceral and subcutaneous adipose tissue compartments：association with metabolic risk factors in the Framingham Heart Study.Circulation.2007，3，116（1）：39-48.

22. Gastaldelli A，Cusi K，Pettiti M，et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.Gastroenterology.2007 Aug，133（2）：496-506.

23. Planel E，Tatebayashi Y，Miyasaka T，et al..Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms.J Neurosci.2007，12，27（50）：13635-48.

24. McIntyre RS，Soczynska JK，Konarski JZ，et al.Should Depressive Syndromes Be Reclassified as“Metabolic Syndrome Type II”？Ann Clin Psychiatry.2007，19（4）：257-64

25. Selwyn AP.Weight reduction and cardiovascular and metabolic disease prevention：clinical trial update.Am J Cardiol.2007，17，100（12A）：33P-37P.

26. Chang YC，Chuang'LM. The role of oxidative stress in the pathogenesis of type 2 diabetes：from molecular mechanism to clinical implication.Am J Transl Res.2010，2 （3）：316-331.

27. Saltiel A R，Kahn CR.Insulin signalling and the regulation of glucose and lipid metabolism.Nature.2001，414：799-806.

28. Meng TC，Buckley DA，Galic S，Tiganis T，Tonks NK.Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B.J Biol Chem.2004，279：37716-25.

29. Klaman LD，Boss O，Peroni OD，Kim JK，Martino JL，Zabolotny JM，Moghal N，Lubkin M，Kim YB，Sharpe AH， Stricker-Krongrad A，Shulman GI，Neel BG，Kahn BB.Increased energy expenditure，decreased adiposity，and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice.Mol Cell Biol.2000，20：5479-89.

30. Sleeman MW，Wortley KE，Lai KM，Gowen LC，Kintner J，Kline WO，Garcia K，Stitt TN，Yancopoulos GD，Wiegand SJ，Glass DJ.Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.Nat Med.2005，11：199-205.

31. Zick Y.Ser/Thr phosphorylation of IRS proteins：a molecular basis for insulin resistance.Sci STKE.2005，268：pe4.

32. Savage DB，Petersen KF，Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev，2007，87：507-520.

33. Garg A.Acquired and inherited lipodystrophies.N Engl J Med，2004，350：1220-1234.

34. Petersen KF，Dufour S，Befroy D，et al.Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.N Engl J Med，2004，350：664-671.

35. Petersen KF，Befroy D，Dufour S，et al.Mitochondrial dysfunction in the elderly：possible role in insulin resistance. Science，2003，300：1140-1142.

36. Li Y，Soos TJ，Li X，Wu J，et al.Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser （1101）.J Biol Chem，2004，279：45304-45307.

37. Kim JK，Fillmore JJ，Sunshine MJ，et al.PKC-theta knockout mice are protected from fatinduced insulin resistance.J Clin Invest，2004，114：823-827.

38. Han S，Liang CP，DeVries-Seimon T，et al.Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.Cell Metab，2006，3：257-266.

39. Liang CP，Han S，Okamoto H，et al.Increased CD36 protein as a response to defective insulin signaling in macrophages.J Clin Invest，2004，113：764-773.

40. Chang YC，Chuang LM.The role of oxidative stress in the pathogenesis of type 2 diabetes：from molecular mechanism to clinical implication Am J Transl Res.2010；2（3）：316-331.

41. Pansuria M，Xi H，Li L，et al.Insulin resistance，metabolic stress，and atherosclerosis. Front Biosci（Schol Ed），2012，4：916-931.

42. Kim MY，Bae JS，Kim TH，et al.Role of transcription factor modifications in the pathogenesis of insulin resistance. Exp Diabetes Res，2012：716425.Published online 2011 October 26.

43. Lamming DW，Ye L，Katajisto P，et al.Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity.Science，2012，335（6076）：1638-1643.